• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Lupin Ltd.
    17 Jul 2025
    2043.40
    2.79%
    Lupin share price increases on rolling out eye medication; details here
    Business Standard
    Lupin's share price rose today after the company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent, in the US market.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd.'s price crossed above 200Day SMA today
    logo
    Novartis India Ltd.
    17 Jul 2025
    918.10
    -0.01%
    Novartis cannot block generic version of Entresto, judge rules
    Business Line
    The judge also reversed her prior ruling that Novartis would likely prove that MSN's tablets looked too similar to Entresto and would confuse consumers
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading below all available SMAs
    logo
    Emcure Pharmaceuticals Ltd.
    17 Jul 2025
    1348.90
    -2.02%
    Emcure Pharma, Sanofi India shares edge higher; what's behind the move?
    Business Standard
    Emcure Pharma stock was quoting at 1,382.5, up 1.5 per cent from the previous day's close of 1,362.5 as the company announced a distribution and promotion partnership with Sanofi India
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1246.2
    Emcure Pharmaceuticals to distribute Sanofi's oral anti-diabetic drugs
    Business Line | 16 Jul 2025
    logo
    Cipla Ltd.
    16 Jul 2025
    1574.60
    0.88%
    Cipla at 90, to provide quality, affordable products, says YK Hamied
    Business Line
    Respiratory and Obesity products, among focus areas reiterated by top management
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above all available SMAs
    logo
    Sanofi Consumer Healthcare India Ltd.
    16 Jul 2025
    5222.50
    1.19%
    Emcure enters distribution agreement with Sanofi for diabetes drugs
    Business Standard
    Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes
    Copy LinkShare onShare on Share on Share on
    Sanofi Consumer Healthcare India Ltd. is trading above all available SMAs
    logo
    Shilpa Medicare Ltd.
    16 Jul 2025
    Dividend
    827.60
    -1.08%
    Why did Shilpa Medicare share jump 5% in trade today? top details here
    Business Standard
    Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA).
    Copy LinkShare onShare on Share on Share on
    Shilpa Medicare Ltd. is trading below its 30 day SMA of 852.1
    logo
    Torrent Pharmaceuticals Ltd.
    16 Jul 2025
    3566.20
    -0.49%
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    NDTV Profit
    Mid-Cap Stocks To Buy, Sell Or Hold: Kush Bohra top picks for July 16 are Torrent Pharma and One97 Communications Ltd.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    logo
    Sun Pharmaceutical Industries Ltd.
    15 Jul 2025
    US FDA Classification
    1616.60
    0.43%
    Sun Pharma gains on US launch of Leqselvi, analysts see strong upside
    Business Standard
    Sun Pharma rises 2.7% as it launches Leqselvi in US following settlement with Incyte, with analysts projecting $200-300 million revenue from the drug in 3-5 years
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    Sun Pharma shares rise 2% on US launch of hair loss drug after settlement
    Business Standard | 15 Jul 2025 3 more
    Sun Pharma, Incyte settle Leqselvi lawsuit; launches alopecia drug in US
    Business Line | 14 Jul 2025
    Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp
    Business Standard | 14 Jul 2025
    Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
    Business Standard | 14 Jul 2025
    logo
    Wockhardt Ltd.
    15 Jul 2025
    1518.00
    -0.61%
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    NDTV Profit
    The leading pharma company's US generics business incurred a loss of $8 million in FY25.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.60% of shares in last quarter. Total pledge stands at 15.64% of promoter holdings
    logo
    AstraZeneca Pharma India Ltd.
    14 Jul 2025
    Show Cause Notice
    9003.50
    -0.75%
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    NDTV Profit
    The receipt of this permission paves way for the marketing of Durvalumab Solution.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd